doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: metform

1 - 5 of 6 <<previous | next>>

Drugs results:

Metformin tablets

Metformin

Also known as Glucophage, Metformin is used to treat a type of diabetes called Type 2 Diabetes. Insulin produced by the pancreas of patients with Type 2 Diabetes is not able to get sugar into the cells of the body where it can work properly. Using Metform more...

Actos tablets

Actos

Actos (also known as Pioglitazone) is an antidiabetic agent and is used to treat Type 2 Diabetes. It may be used alone, with insulin, or with another type of diabetes medicine. Be sure to tell your doctor of any allergies you more...

Avandamet tablet

Avandamet

Avandamet, a combination of Rosiglitazone and Metformin, is used to treat high blood sugar that is caused by Type 2 Diabetes. Rosiglitazone helps your body use insulin better and it reduces the actual amount of insulin in your body. Metformin reduces the more...

Glucophage tablets

Glucophage

Also known as Metformin, Glucophage is used to treat a type of diabetes called Type 2 Diabetes. Insulin produced by the pancreas of patients with Type 2 Diabetes is not able to get sugar into the cells of the body where it can work properly. Using Glucoph more...

Pioglitazone tablets

Pioglitazone

Pioglitazone is an oral diabetes medicine that help control blood sugar levels for people with type 2 diabetes mellitus or the non-insulin dependent diabetes mellitus (NIDDM). These people do not use daily insulin injections. more...

Diseases results:

Diabetes
Insulin resistance

Articles results:

Prescription Drug Prices Vary By Neighborhood In New York City, According To A City Council Report
New York City prescription drug prices vary depending on the pharmacy, with the difference in some cases as much as 700% for the same medication, according to a report by the New York City Council, the New York Post reports (Edozien, New York Post, 10/5).


Novo Nordisk Withdraws Its Application To Extend The Marketing Authorisations For NovoNorm And Prandin
The European Medicines Agency has been formally notified by Novo Nordisk A/S of its decision to withdraw its application for a change to the marketing authorisations for NovoNorm (repaglinide) and Prandin (repaglinide) 0.5 mg, 1 mg and 2 mg tablets. NovoNorm was first authorised in the European Union on 17 August 1998 and Prandin on 29 January 2001. Both products are currently indicated for use in patients who have non-insulin-dependent diabetes (type-2 diabetes).


Novartis Highlights Strong R&D Pipeline, Plans For Multiple New Product Launches And Novel Projects Moving Into Late-stage Trials
Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.


Meeting Highlights From The Committee For Medicinal Products For Human Use (CHMP), 22-24 January 2007
Initial marketing authorisation applicationsThe Committee for Medicinal Products for Human Use (CHMP) gave positive opinions recommending the granting of marketing authorisations for Januvia (sitagliptin) and Xelevia (sitagliptin), from Merck Sharp & Dohme. Both products are intended for the treatment of type-II diabetes mellitus in combination with either metformin or, in certain patients, a PPARg agonist (i.e.


FDA Approves Combination Drug Janumet For Type 2 Diabetes
The US Food and Drug Administration has approved a new combination drug called Janumet that combines a new drug and an older drug in a more convenient form for people with type 2 diabetes.Janumet is made by Merck & Co and according to the company it is the first and only tablet that combines a dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin (also known as Januvia), and metformin for treating patients with type 2 diabetes.




1 - 5 of 6 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.